CS173624B2 - - Google Patents

Info

Publication number
CS173624B2
CS173624B2 CS1591A CS159173A CS173624B2 CS 173624 B2 CS173624 B2 CS 173624B2 CS 1591 A CS1591 A CS 1591A CS 159173 A CS159173 A CS 159173A CS 173624 B2 CS173624 B2 CS 173624B2
Authority
CS
Czechoslovakia
Application number
CS1591A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE2210672A priority Critical patent/DE2210672C3/de
Application filed filed Critical
Publication of CS173624B2 publication Critical patent/CS173624B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/929Vasodilator
CS1591A 1972-03-06 1973-03-06 CS173624B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2210672A DE2210672C3 (ja) 1972-03-06 1972-03-06

Publications (1)

Publication Number Publication Date
CS173624B2 true CS173624B2 (ja) 1977-02-28

Family

ID=5838025

Family Applications (2)

Application Number Title Priority Date Filing Date
CS1591A CS173624B2 (ja) 1972-03-06 1973-03-06
CS5080A CS173649B2 (ja) 1972-03-06 1973-03-06

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS5080A CS173649B2 (ja) 1972-03-06 1973-03-06

Country Status (25)

Country Link
US (1) US3883540A (ja)
JP (1) JPS5626657B2 (ja)
KR (1) KR780000010B1 (ja)
AT (1) AT324335B (ja)
AU (1) AU468879B2 (ja)
BE (1) BE796274A (ja)
BG (2) BG22389A3 (ja)
CA (1) CA1045138A (ja)
CH (2) CH579049A5 (ja)
CS (2) CS173624B2 (ja)
DD (1) DD107456A5 (ja)
DE (1) DE2210672C3 (ja)
DK (1) DK136900C (ja)
ES (2) ES412319A1 (ja)
FR (1) FR2183674B1 (ja)
GB (1) GB1384031A (ja)
HU (1) HU164867B (ja)
IE (1) IE37366B1 (ja)
IL (1) IL41668A (ja)
LU (1) LU67146A1 (ja)
NL (1) NL7303135A (ja)
PL (2) PL92117B1 (ja)
RO (2) RO63067A (ja)
SU (6) SU468416A3 (ja)
ZA (1) ZA7301500B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
US3974278A (en) * 1973-07-12 1976-08-10 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters
CH607848A5 (ja) * 1974-06-04 1978-11-30 Bayer Ag
FR2320750B1 (ja) * 1975-08-12 1979-09-28 Hexachimie
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
SU798099A1 (ru) * 1978-03-06 1981-01-23 Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp 1-Бензил-2,6-диметил-4-о-или-M-НиТРОфЕНил-3,5-диэТОКСиКАРбОНил- 1,4-дигидРОпиРидиНы, пРО Вл ющиЕКОРОНАРОдилАТиРующую АКТиВНОСТь
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2,6-dimethyl-4- (2,3-dichlorophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl 5-ethyl ester
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IL68604D0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US5237089A (en) * 1986-02-07 1993-08-17 Basf Aktiengesellschaft Nitro or amino substituted phenylalkyl or phenylalkenyl carboxylic acid derivatives
DE3724399A1 (de) * 1987-07-23 1989-02-02 Basf Ag Phenylalkenylcarbonsaeuren und deren ester
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (en) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. 1,4-dihydropyridine derivatives useful against tumour cells
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc TREATMENT OF HEPATIC DISORDERS THROUGH THE ADMINISTRATION OF CONJUGATES OF THE PROTEIN ASSOCIATED WITH THE RECEIVER (RAP).
CN102316902B (zh) 2009-02-20 2014-09-24 to-BBB控股股份有限公司 基于谷胱甘肽的药物递送系统
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CA2854252C (en) * 2011-11-24 2016-11-29 Lipidart Kutato Fejleszto Es Tanacsado Kft. 1,4-dihydropyridine derivatives with hsp modulating activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
DE1963186C3 (ja) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen
DE2013431C3 (ja) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen
DE2117572C3 (ja) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen

Also Published As

Publication number Publication date
IL41668A (en) 1977-02-28
SU468416A3 (ru) 1975-04-25
DD107456A5 (ja) 1974-08-05
CA1045138A1 (ja)
BG20351A3 (ja) 1975-11-05
ZA7301500B (en) 1973-11-28
RO62798A (en) 1977-11-15
IE37366B1 (en) 1977-07-06
DE2210672B2 (ja) 1979-07-12
US3883540A (en) 1975-05-13
FR2183674B1 (ja) 1976-10-22
RO63067A (en) 1978-05-15
BE796274A1 (ja)
ES439487A1 (es) 1977-02-01
KR780000010B1 (en) 1978-03-04
CH578530A5 (ja) 1976-08-13
CS173649B2 (ja) 1977-02-28
LU67146A1 (ja) 1973-05-22
BE796274A (fr) 1973-09-05
DK136900C (da) 1978-05-22
PL89257B1 (ja) 1976-11-30
CA1045138A (en) 1978-12-26
SU470958A3 (ru) 1975-05-15
AU5287673A (en) 1975-03-27
JPS4899179A (ja) 1973-12-15
PL92117B1 (ja) 1977-03-31
DE2210672C3 (ja) 1980-03-20
BG22389A3 (ja) 1977-02-20
ES412319A1 (es) 1976-05-01
HU164867B (ja) 1974-05-28
SU464111A3 (ru) 1975-03-15
DE2210672A1 (de) 1973-09-20
JPS5626657B2 (ja) 1981-06-19
AT324335B (de) 1975-08-25
NL7303135A (ja) 1973-09-10
CH579049A5 (ja) 1976-08-31
SU466656A3 (ru) 1975-04-05
SU451241A3 (ru) 1974-11-25
DK136900B (da) 1977-12-12
SU457217A3 (ru) 1975-01-15
GB1384031A (en) 1975-02-19
IE37366L (en) 1973-09-06
AU468879B2 (en) 1975-03-27
FR2183674A1 (ja) 1973-12-21
IL41668D0 (en) 1973-05-31

Similar Documents

Publication Publication Date Title
FR2196720A5 (ja)
FR2203126B1 (ja)
FR2203848B1 (ja)
FR2199876A5 (ja)
JPS4890217A (ja)
JPS4911804A (ja)
IN140712B (ja)
JPS4964950A (ja)
JPS505977A (ja)
FR2189670A1 (ja)
FR2196880B1 (ja)
FR2208473A5 (ja)
DE2330578B2 (ja)
DE2247067B2 (ja)
IN139155B (ja)
FR2203699A1 (ja)
FR2198061B1 (ja)
JPS4915845A (ja)
JPS49133056A (ja)
FR2205530B1 (ja)
JPS5234701B2 (ja)
JPS5437873B2 (ja)
FR2211312B3 (ja)
JPS5130211B2 (ja)
JPS5017573B2 (ja)